Related Experiment Videos
Understanding the Cost Consequences of Pharmacist Roles in Managing Long-Term Illnesses: A Systematic Review
1Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Kingdom Saudi Arabia.
Saudi Medical Journal
|June 4, 2026
Summary
Pharmacist-led services improve medication management for chronic conditions, leading to better adherence and fewer problems. These interventions can reduce overall healthcare costs and improve patient outcomes, supporting closer pharmacist integration in care teams.
Area of Science:
- Pharmacoeconomics
- Health Services Research
- Clinical Pharmacy
Background:
- Chronic illnesses require complex medication management.
- Pharmacist-led interventions can optimize medication use.
- Economic outcomes of these services require comprehensive evaluation.
Purpose of the Study:
- To review the economic impact of pharmacist-led services on patients with long-term illnesses.
- To synthesize evidence on cost-effectiveness of pharmacist involvement in chronic disease management.
Main Methods:
- Systematic literature review following PRISMA 2020 guidelines.
- Inclusion of studies on medication management services (e.g., MTM, deprescribing) in chronic diseases.
- Quality assessment using MMAT and Drummond checklist for economic evaluations.
Main Results:
- Pharmacist involvement reduced medication-related problems and improved adherence.
- Interventions led to lower healthcare costs through reduced adverse events and hospitalizations.
- Some economic evaluations indicated cost savings from pharmacist-led medication management.
Conclusions:
- Pharmacist-led services improve clinical outcomes and economic benefits for chronic disease patients.
- Direct pharmacist involvement in medication management enhances care.
- Integration of pharmacists into chronic care teams is recommended for better health economics.
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...